These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 373432)
61. 1995 National Clinical Pharmacy Services Study. Raehl CL; Bond CA; Pitterle ME Pharmacotherapy; 1998; 18(2):302-26. PubMed ID: 9545150 [TBL] [Abstract][Full Text] [Related]
62. Justification of a pharmacy intravenous admixture service in an Australian hospital. Plumridge RJ; Maher M Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462 [TBL] [Abstract][Full Text] [Related]
63. Clinical services provided by staff pharmacists in a community hospital. Garrelts JC; Smith DF Am J Hosp Pharm; 1990 Sep; 47(9):2011-5. PubMed ID: 2244945 [TBL] [Abstract][Full Text] [Related]
64. Calculation of product waste in i.v. admixture programs. Vogel DP; Eck TA; Witte KW Am J Hosp Pharm; 1986 Apr; 43(4):952-3. PubMed ID: 3706344 [No Abstract] [Full Text] [Related]
65. Pharmacists and nurses benefit from an I.V. additive program. Ragland JB; Knoll KR Hospitals; 1968 Aug; 42(16):136-40. PubMed ID: 5666020 [No Abstract] [Full Text] [Related]
67. Design and implementation of a quality-assurance program for pharmaceutical services. Horowitz KN; Lamnin M Am J Hosp Pharm; 1980 Jan; 37(1):82-4. PubMed ID: 7361777 [TBL] [Abstract][Full Text] [Related]
68. Monitoring waste in an intravenous admixture program. Mitchell SR Am J Hosp Pharm; 1987 Jan; 44(1):106-11. PubMed ID: 3826083 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of two sterility testing methods for intravenous admixtures. Condella F; Eichelberger K; Foote LC; Griffin RE Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270 [TBL] [Abstract][Full Text] [Related]
71. Hospital pharmacy in Australia. Miller BR Am J Hosp Pharm; 1978 Jun; 35(6):673-7. PubMed ID: 665680 [TBL] [Abstract][Full Text] [Related]
72. Implementation and operation of a hospital pediatric satellite pharmacy. Castile JA; Castile RG; O'Connell EJ Hosp Pharm; 1980 Sep; 15(9):457-62, 466, 468-9. PubMed ID: 10248359 [TBL] [Abstract][Full Text] [Related]
73. [Pharmacy Department standard procedures for clinical trial development]. Pérez Peiró C; Porta Oltra B; Cholvi Llovell M; Jiménez Torres NV Farm Hosp; 2004; 28(1):36-47. PubMed ID: 15012177 [TBL] [Abstract][Full Text] [Related]
74. Pharmacy-coordinated investigational drug services. Stolar MH; Gabriel T; Grant KL; Koeller J; Letendre DE Am J Hosp Pharm; 1982 Mar; 39(3):232-6. PubMed ID: 7072723 [TBL] [Abstract][Full Text] [Related]
75. Cost containment measures in hospital pharmacy: a bibliography. Treleaven S; Einarson TR Can J Hosp Pharm; 1990 Feb; 43(1):17-25. PubMed ID: 10106452 [TBL] [Abstract][Full Text] [Related]
76. Procedures for handling intravenous additives. The nursing team approach. Paoloni CU Hosp Manage; 1969 Sep; 108(3):12-22. PubMed ID: 5809799 [No Abstract] [Full Text] [Related]
77. The expanding role of pharmacy. Interview by Nancy Agresta. Durgin J Hosp Formul; 1980 Apr; 15(4):287-90, 293. PubMed ID: 10245911 [No Abstract] [Full Text] [Related]
78. [Drug supply chain safety in hospitals: current data and experience of the Grenoble university hospital]. Bedouch P; Baudrant M; Detavernier M; Rey C; Brudieu E; Foroni L; Allenet B; Calop J Ann Pharm Fr; 2009 Jan; 67(1):3-15. PubMed ID: 19152845 [TBL] [Abstract][Full Text] [Related]
79. Clinical pharmacy services in a rehabilitation facility. Merryfield DW; Ayers TG; Wilkinson CA; Williams RB Am J Hosp Pharm; 1983 Sep; 40(9):1529-32. PubMed ID: 6624757 [TBL] [Abstract][Full Text] [Related]